RE:Correct me if I'm wrong@dude, yes but it's probably best to work on a much more conservative scenario of an already ambitious $100M/year earnings. Be it only to be
extra cautious.
Whatever else comes on top of that will simply be gravy over an already hefty target 5 times that of 2020!
This said, whatever scenario used, be it the most conservative (say, $40M/ for 2021) or insane (say, $200M for 2021) we are sure to be at $1+ on relatively short order (i.e. around end-May), which should, in due course, put a smile on just about anyone holding DM shares.
Dudeforever wrote: The numbers, should we get this up to 50,000 tests per week, are:
50,000 x 175 = $8,750,000 per week
$8,750,000 x 13.1429 weeks (July, August, September) = $115,000,375
If we do indeed reach these lofty targets we will be closer to $7 per share. Doing over $100million in a quarter of high-margin revenue is big boy territory.